U.S. Food and Drug Administration (FDA) · United States
FDA False or Misleading Medical Device Claims
Device promotion must not make false, absolute or unsubstantiated performance, safety or superiority claims; quantified and comparative claims need a cited basis.
What is FDA False or Misleading Medical Device Claims?
Device promotion must not make false, absolute or unsubstantiated performance, safety or superiority claims; quantified and comparative claims need a cited basis. Apply to any US medical device ad, label, PDP or sales material that makes performance, safety or comparative claims.
general_audience, general_adults_18plus, patients, health_professionals, customers · Medical Device · healthcare
Where does this rule apply?
United States
Which marketing channels are covered?
all_channels
When does this rule take effect?
2026-05-10
What does this rule require?
Device promotion must not make false, absolute or unsubstantiated performance, safety or superiority claims; quantified and comparative claims need a cited basis.
How can marketing teams comply?
Apply to any US medical device ad, label, PDP or sales material that makes performance, safety or comparative claims.
What is FDA False or Misleading Medical Device Claims?
Device promotion must not make false, absolute or unsubstantiated performance, safety or superiority claims; quantified and comparative claims need a cited basis.
Who does this rule apply to?
general_audience, general_adults_18plus, patients, health_professionals, customers · Medical Device · healthcare
FDA's food labeling rules require a Nutrition Facts panel and other label elements and restrict nutrient and 'healthy' claims to foods meeting FDA criteria; the amended 'healthy' definition is effective April 28, 2025 with compliance required by Feb. 25, 2028.
Requires DTC Rx ads to present the major risk statement clearly, conspicuously and neutrally, to provide adequate provision for full prescribing information in broadcast, and to include a brief summary in print.
Supplements, cosmetics, foods and CBD products become unapproved drugs if their marketing claims to diagnose, treat, cure, mitigate or prevent disease, and cosmetics also may not claim to affect body structure or function.
OTC external drug products covered by 21 CFR 358 (warts, corns and calluses, ingrown toenails, lice, dandruff, seborrheic dermatitis, psoriasis) may only claim the uses and actives in their monograph.
FDA food additive rules require additives to be approved or GRAS, and labeling rules require certified colors and preservatives to be declared properly; 'no artificial' or 'no preservative' claims must match the ingredient list.
Food and supplement labels may link a substance to reduced disease risk only through FDA-authorized or qualified health claims, in the required form, and only on foods meeting nutrient eligibility; disease treatment claims are not allowed.
Request a free compliance scan of your homepage and book a time with Warrant.